ArticleHead & neck2022

Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single-institution retrospective study.

Neeraja Konuthula et al.PubMed ↗Publisher ↗

No numbers read from the abstract.